Evidence map›Paper›PMID 36962924›Full record

ArticlePLOS global public health2022

Cost of wastewater-based environmental surveillance for SARS-CoV-2: Evidence from pilot sites in Blantyre, Malawi and Kathmandu, Nepal.

Lucky G Ngwira, Bhawana Sharma, Kabita Bade Shrestha, Sushil Dahal, Reshma Tuladhar, Gerald Manthalu, Ben Chilima, Allone Ganizani, Jonathan Rigby, Oscar Kanjerwa and 5 more

Full text read
In one paragraph

Article in PLOS global public health, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed.

  1. Review
  2. Environmental surveillance of pathogens in Africa.Applied and environmental microbiology · 2026
    Review
  3. Article
  4. Article
  5. Article
  6. Real-time, multi-pathogen wastewater genomic surveillance with Freyja 2.medRxiv : the preprint server for health sciences · 2025
    Article
  7. The potential of long-term wastewater-based surveillance to predict COVID-19 waves peak in Mexico.Water environment research : a research publication of the Water Environment Federation · 2025
    Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Lucky G NgwiraMalawi Liverpool Wellcome Research Programme, Blantyre, Malawi.ORCID https://orcid.org/0000-0002-2695-8917
Bhawana SharmaEnvironment and Public Health Organization, Kathmandu, Nepal.
Kabita Bade ShresthaInnovative Solution Pvt. Ltd, Lalitpur, Nepal.ORCID https://orcid.org/0000-0003-4970-3359
Sushil DahalEnvironment and Public Health Organization, Kathmandu, Nepal.
Reshma TuladharDepartment of Microbiology, Tribhuvan University, Kathmandu, Nepal.ORCID https://orcid.org/0000-0001-9583-5374
Gerald ManthaluDepartment of Planning and Policy, Ministry of Health, Lilongwe, Malawi.
Ben ChilimaPublic Health Institute of Malawi, Ministry of Health, Lilongwe, Malawi.
Allone GanizaniEnvironmental Department, Ministry of Health, Lilongwe, Malawi.
Jonathan RigbyMalawi Liverpool Wellcome Research Programme, Blantyre, Malawi.ORCID https://orcid.org/0000-0001-5143-0981
Oscar KanjerwaMalawi Liverpool Wellcome Research Programme, Blantyre, Malawi.ORCID https://orcid.org/0000-0002-5472-0535
Kayla BarnesMalawi Liverpool Wellcome Research Programme, Blantyre, Malawi.
Catherine AnscombeMalawi Liverpool Wellcome Research Programme, Blantyre, Malawi.
Joseph Mfutso-BengoKamuzu University of Health Sciences, Blantyre, Malawi.
Nicholas FeaseyMalawi Liverpool Wellcome Research Programme, Blantyre, Malawi.
Mercy MvunduraMedical Devices and Health Technologies, PATH, Seattle, Washington, United States of America.ORCID https://orcid.org/0000-0002-7711-9558

Funding

Identifying genetic determinants of Rotavirus Vaccine Failure in Malawian ChildrenK01TW010853 · FIC · HARVARD SCHOOL OF PUBLIC HEALTH · PI BARNES, KAYLA G · 2018 to 2022
$731k
FIC NIH HHS K01 TW010853Wellcome Trust
6 · The paper itself

Abstract

Environmental surveillance of rivers and wastewater for SARS-CoV-2 detection has been explored as an innovative way to surveil the pandemic. This study estimated the economic costs of conducting wastewater-based environmental surveillance for SARS-CoV-2 to inform decision making if countries consider continuing these efforts. We estimated the cost of two SARS-CoV-2 environmental surveillance pilot studies conducted in Blantyre, Malawi, and Kathmandu, Nepal. The cost estimation accounted for the consumables, equipment, and human resource time costs used for environmental surveillance from sample selection until pathogen detection and overhead costs for the projects. Costs are reported in 2021 US$ and reported as costs per month, per sample and person per year. The estimated costs for environmental surveillance range from $6,175 to $8,272 per month (Blantyre site) and $16,756 to $30,050 (Kathmandu site). The number of samples processed per month ranged from 84 to 336 at the Blantyre site and 96 to 250 at the Kathmandu site. Consumables costs are variable costs influenced by the number of samples processed and are a large share of the monthly costs for ES (ranging from 39% to 72%). The relatively higher costs per month for the Kathmandu site were attributable to the higher allocation of dedicated human resources and equipment to environmental surveillance for SARS-CoV-2 compared to the Blantyre site where these resources were shared with other activities. The average cost per sample ranged from $25 to $74 (Blantyre) and $120 to $175 (Kathmandu). There were associated economies of scale for human resources and equipment costs with increased sample processing and sharing of resources with other activities. The cost per person in the catchment area per year ranged from $0.07 to $0.10 in Blantyre and $0.07 to $0.13 in Kathmandu. Environmental surveillance may be a low-cost early warning signal for SARS-CoV-2 that can complement other SARS-CoV2 monitoring efforts.

Identifiers

PMID36962924
PMCPMC10021894

What OpenQuestion holds

Textfull text, public
LicenceCC BY
measurements read46
identifiers read8
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.